16.85 USD
0 (0%)
VECT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. VECT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VECT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year VECT has reported negative net income.
- VECT had a negative operating cash flow in the past year.
1.2 Ratios
- The profitability ratios for VECT are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for VECT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for VECT has been increased compared to 1 year ago.
- The debt/assets ratio for VECT is higher compared to a year ago.
2.2 Solvency
- VECT has an Altman-Z score of 17.24. This indicates that VECT is financially healthy and has little risk of bankruptcy at the moment.
- VECT's Altman-Z score of 17.24 is amongst the best of the industry. VECT outperforms 93.55% of its industry peers.
- VECT has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
- VECT has a Debt to Equity ratio of 0.05. This is comparable to the rest of the industry: VECT outperforms 40.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 17.24 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 9.14 indicates that VECT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 9.14, VECT is in the better half of the industry, outperforming 71.13% of the companies in the same industry.
- VECT has a Quick Ratio of 9.14. This indicates that VECT is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 9.14, VECT is doing good in the industry, outperforming 71.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.14 | ||
| Quick Ratio | 9.14 |
3. Growth
3.1 Past
- VECT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.00%, which is quite impressive.
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, VECT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.85% on average per year.
- VECT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 81.29% yearly.
EPS Next Y8.67%
EPS Next 2Y1.86%
EPS Next 3Y1.79%
EPS Next 5Y19.85%
Revenue Next Year-96.99%
Revenue Next 2Y-36.77%
Revenue Next 3Y44.85%
Revenue Next 5Y81.29%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- VECT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year VECT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.86%
EPS Next 3Y1.79%
5. Dividend
5.1 Amount
- No dividends for VECT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VectivBio Holding AG / VECT FAQ
Can you provide the ChartMill fundamental rating for VectivBio Holding AG?
ChartMill assigns a fundamental rating of 2 / 10 to VECT.
What is the valuation status for VECT stock?
ChartMill assigns a valuation rating of 0 / 10 to VectivBio Holding AG (VECT). This can be considered as Overvalued.
What is the profitability of VECT stock?
VectivBio Holding AG (VECT) has a profitability rating of 0 / 10.
What is the financial health of VectivBio Holding AG (VECT) stock?
The financial health rating of VectivBio Holding AG (VECT) is 5 / 10.
What is the expected EPS growth for VectivBio Holding AG (VECT) stock?
The Earnings per Share (EPS) of VectivBio Holding AG (VECT) is expected to grow by 8.67% in the next year.